Phase Ii Study Of Sintilimab Combined With Flot Regimen For Neoadjuvant Treatment Of Gastric Or Gastroesophageal Junction (Gej) Adenocarcinoma

Annals of Oncology(2020)

引用 9|浏览4
暂无评分
摘要
216Background: Perioperative treatments have significantly improved survival in patients with resectable gastric cancer, increasing 5-year overall survival from 23% with surgery alone to 45% with F...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要